• Mashup Score: 25

    Read recommendations for the screening, monitoring, and treatment of interstitial lung disease (ILD) in patients with systemic autoimmune rheumatic disease.

    Tweet Tweets with this article
    • ICYMI. Two new ACR Clinical Practice Guideline Summaries provide recommendations regarding screening, monitoring, & treatment of interstitial lung disease in people with systemic autoimmune #rheum diseases. View → https://t.co/WGMZo6LEZh #ILD https://t.co/BJ2YyFDu5B

  • Mashup Score: 0

    “Guidance was needed for which tests to use for screening and monitoring this particular disease,” said lead author Sindhu R. Johnson, MD, PhD. The full manuscript will be published by early 2024.

    Tweet Tweets with this article
    • The @ACRheum has released a summary of upcoming guidelines on screening, monitoring, and treatment for interstitial lung disease in patients with systemic autoimmune rheumatic disease. #ILD #RheumTwitter https://t.co/hKoRNJ8KTk

  • Mashup Score: 3

    Read recommendations for the screening, monitoring, and treatment of interstitial lung disease (ILD) in patients with systemic autoimmune rheumatic disease.

    Tweet Tweets with this article
    • Two new ACR Clinical Practice Guideline Summaries provide recommendations regarding screening, monitoring, & treatment of #ILD in people with systemic autoimmune #rheum diseases, including #RA, #SSc, & idiopathic inflammatory myopathies. View → https://t.co/WGMZo6LEZh https://t.co/VNYlmymKdh

  • Mashup Score: 14

    The field of pulmonary hypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of therapeutic options. The five main groups of pulmonary hypertension differ in epidemiology, causes and risk factors, underlying disease mechanisms, and clinical presentation. Approaches to diagnosis and management reflect the distinctive features of each condition. In the first of a Series of three papers, Marc Humbert and colleagues provide an

    Tweet Tweets with this article
    • The field of #pulmonaryhypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of #therapeutic options Find out more in a new @LancetRespirMed Series https://t.co/ALcvKnFvoM #PH #PAH #CTEPH #COPD #ILD https://t.co/9xiHMp5yO4

  • Mashup Score: 0

    Patients with chronic lung diseases, particularly interstitial lung disease and chronic obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in clinical deterioration, worsening of oxygen uptake, and an increased mortality risk. Pulmonary hypertension can develop and progress independently from the underlying lung disease. The pulmonary vasculopathy is distinct from that of other forms of pulmonary hypertension, with vascular ablation due to loss of small pulmonary vessels being a key feature.

    Tweet Tweets with this article
    • Karen Olsson and colleagues emphasise the pressing need for safe, effective treatment options and non-invasive diagnostic tools to detect and characterise #PulmonaryHypertension in patients with chronic lung disease https://t.co/yeHFOQ6DyM #PH #COPD #ILD #CPFE https://t.co/vfpkdVpv93

  • Mashup Score: 0

    Inhaled treprostinil was safe in patients with pulmonary hypertension associated with interstitial lung disease over 1 year and sustained improved exercise capacity, according to study results published in European Respiratory Journal.“I hope the impact of this trial and the clear benefit on everyday clinicians is greater awareness so that they look for the disease,” Aaron B. Waxman,

    Tweet Tweets with this article
    • “I hope the impact of this trial and the clear benefit on everyday clinicians is greater awareness so that they look for [pulmonary #hypertension-#ILD]," Aaron B. Waxman, MD, PhD, FACP, FCCP, at @BrighamWomens, told Healio. https://t.co/E5sZQXTl8u

  • Mashup Score: 0

    Inhaled treprostinil was safe in patients with pulmonary hypertension associated with interstitial lung disease over 1 year and sustained improved exercise capacity, according to study results published in European Respiratory Journal.“I hope the impact of this trial and the clear benefit on everyday clinicians is greater awareness so that they look for the disease,” Aaron B. Waxman,

    Tweet Tweets with this article
    • Published in @ERSpublications: Inhaled #treprostinil was safe in patients with pulmonary #hypertension associated with interstitial #lung disease (#ILD) over 1 year and sustained improved exercise capacity. https://t.co/E5sZQXTl8u